Development and Validation of a Machine Learning Individualized Treatment Rule in First-Episode Schizophrenia-Reference-Cited by-同舟云学术

Development and Validation of a Machine Learning Individualized Treatment Rule in First-Episode Schizophrenia

Published:2020-02-21 Issue:2 Volume:3 Page:e1921660
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Wu Chi-Shin¹,Luedtke Alex R.²³,Sadikova Ekaterina⁴⁵,Tsai Hui-Ju⁶,Liao Shih-Cheng¹,Liu Chen-Chung¹,Gau Susan Shur-Fen¹,VanderWeele Tyler J.⁵⁷,Kessler Ronald C.⁴

Affiliation:

1. Department of Psychiatry, National Taiwan University Hospital & College of Medicine, National Taiwan University, Taipei City, Taiwan

2. Department of Statistics, University of Washington, Seattle

3. Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington

4. Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts

5. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts

6. Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan

7. Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2761551/wu_2020_oi_190817.pdf

Reference46 articles.

1. Epidemiology of schizophrenia: the global burden of disease and disability.;Jablensky;Eur Arch Psychiatry Clin Neurosci,2000

2. The humanistic and economic burden of providing care for a patient with schizophrenia.;Csoboth;Int J Soc Psychiatry,2015

3. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.;Hasan;World J Biol Psychiatry,2012

4. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.;Kahn;Lancet,2008

5. Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies.;Alvarez-Jimenez;Schizophr Res,2012

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarker discovery using machine learning in the psychosis spectrum;Biomarkers in Neuropsychiatry;2024-12

2. Prediction of Clinical Outcomes in Psychotic Disorders Using Artificial Intelligence Methods: A Scoping Review;Brain Sciences;2024-08-29

3. Measurement-Based Care and Applying Statistical Concepts to the Individual Patient;Clinical Reasoning and Decision-Making in Psychiatry;2024-03-31

4. Assessing treatment switch among patients with multiple sclerosis: A machine learning approach;Exploratory Research in Clinical and Social Pharmacy;2023-09

5. Role of artificial intelligence in pharmacy practice: A narrative review;JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY;2023-07-17